EU Falsified Medicines Directive (FMD)
The EU Falsified Medicines Directive (FMD) has been introduced across the European Union to address the increasingly common issue of falsified medicines entering the legitimate medicines supply chain. Falsified medicines include those with little or no active ingredients, the wrong active ingredient, fake or tampered packaging, or stolen products. Their existence poses a safety risk to patients and undermines confidence in genuine products.
About this page
Updated on Wednesday, 23 October 2019